DNA from these 33 EGFR-TKI naïve NSCLC patients was first evaluated for tumor content by determining the VAF of the EGFR driver mutation (E19 del and L858R) by ddPCR. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.